Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment

A Bertoni, F Penco, H Mollica, P Bocca… - Journal of Allergy and …, 2022 - Elsevier
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may
result in a severe pneumonia associated with elevation of blood inflammatory parameters …
被引用次数：30 相关文章
[PDF] researchgate.net

[PDF][PDF] Spontaneous NLRP3 inflammasome-driven IL-1-b secretion is induced in severe COVID-19 patients and responds to anakinra treatment

A Bertoni, F Penco, H Mollica, P Bocca, I Prigione… - 2022 - researchgate.net
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may
result in a severe pneumonia associated with elevation of blood inflammatory parameters …

Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment

A Bertoni, F Penco, H Mollica… - The Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may
result in a severe pneumonia associated with elevation of blood inflammatory parameters …
[HTML] nih.gov

[HTML][HTML] Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment

A Bertoni, F Penco, H Mollica, P Bocca… - The Journal of Allergy …, 2022 - ncbi.nlm.nih.gov
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may
result in a severe pneumonia associated with elevation of blood inflammatory parameters …

Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment.

A Bertoni, F Penco, H Mollica, P Bocca… - The Journal of Allergy …, 2022 - europepmc.org
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may
result in a severe pneumonia associated with elevation of blood inflammatory parameters …

Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment.

A Bertoni, F Penco, H Mollica, P Bocca, I Prigione… - 2022 - cabidigitallibrary.org
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may
result in a severe pneumonia associated with elevation of blood inflammatory parameters …

Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment

A Bertoni, F Penco, H Mollica, P Bocca… - Journal of Allergy and …, 2022 - jacionline.org
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may
result in a severe pneumonia associated with elevation of blood inflammatory parameters …
[PDF] academia.edu

[PDF][PDF] Spontaneous NLRP3 inflammasome-driven IL-1-b secretion is induced in severe COVID-19 patients and responds to anakinra treatment

A Bertoni, F Penco, H Mollica, P Bocca, I Prigione… - 2022 - academia.edu
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may
result in a severe pneumonia associated with elevation of blood inflammatory parameters …
[HTML] jacionline.org

[HTML][HTML] Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment

A Bertoni, F Penco, H Mollica, P Bocca… - Journal of Allergy and …, 2022 - jacionline.org
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may
result in a severe pneumonia associated with elevation of blood inflammatory parameters …